MiMedx Group Q1 2024 Adj EPS $0.07 Beats $0.04 Estimate, Sales $84.709M Beat $79.361M Estimate
MiMedx Group Q1 2024 Adj EPS $0.07 Beats $0.04 Estimate, Sales $84.709M Beat $79.361M Estimate
MimedX集團2024年第一季度調整後每股收益0.07美元超過預期的0.04美元，銷售額8,4709萬美元超過7,9361萬美元的預期
MiMedx Group (NASDAQ:MDXG) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.04 by 75 percent. This is a 333.33 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $84.709 million which beat the analyst consensus estimate of $79.361 million by 6.74 percent. This is a 18.18 percent increase over sales of $71.676 million the same period last year.
MimedX集團（納斯達克股票代碼：MDXG）公佈的季度收益爲每股0.07美元，比分析師普遍預期的0.04美元高出75％。與去年同期每股虧損0.03美元（0.03）相比，增長了333.33％。該公司公佈的季度銷售額爲8,4709萬美元，比分析師普遍預期的7,936.1萬美元高出6.74％。這比去年同期的7167.6萬美元的銷售額增長了18.18％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。